Adaptive Biotechnologies
(NASDAQ:ADPT)
$3.24
0.04[1.25%]
At close: Jun 21
$3.24
0[0.00%]
After Hours: 5:32PM EDT
Consensus Rating1
Overweight
Highest Price Target1
$52.00
Lowest Price Target1
$5.00
Consensus Price Target1
$13.50

Adaptive Biotechnologies (NASDAQ:ADPT) Stock, Analyst Ratings, Price Targets, Predictions

Adaptive Biotechnologies Corp has a consensus price target of $13.5, established from looking at the 23 latest analyst ratings. The last 3 analyst ratings were released from BTIG, Goldman Sachs, and JP Morgan on April 4, 2024, February 16, 2024, and February 15, 2024. With an average price target of $6 between BTIG, Goldman Sachs, and JP Morgan, there's an implied 85.19% upside for Adaptive Biotechnologies Corp from these 3 analyst ratings.

Analyst Trends and Forecast
1
1
Feb
0
0
0
0
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
2.4
Sell
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

BTIG
Goldman Sachs
JP Morgan
Piper Sandler
Morgan Stanley

1calculated from analyst ratings

Analyst Ratings for Adaptive Biotechnologies

Buy NowGet Alert
04/04/2024Buy Now54.32%BTIG
Mark Massaro
$6 → $5MaintainsBuyGet Alert
02/16/2024Buy Now54.32%Goldman Sachs
Salveen Richter
$11 → $5MaintainsNeutralGet Alert
02/15/2024Buy Now146.91%JP Morgan
Rachel Vatnsdal
$11 → $8MaintainsOverweightGet Alert
11/13/2023Buy Now85.19%Piper Sandler
David Westenberg
$13 → $6MaintainsOverweightGet Alert
10/24/2023Buy Now208.64%Morgan Stanley
Tejas Savant
$13 → $10MaintainsEqual-WeightGet Alert
10/16/2023Buy Now301.23%Piper Sandler
David Westenberg
$14 → $13MaintainsOverweightGet Alert
08/08/2023Buy Now332.1%Piper Sandler
David Westenberg
$15 → $14MaintainsOverweightGet Alert
08/04/2023Buy Now301.23%Morgan Stanley
Tejas Savant
$14 → $13MaintainsEqual-WeightGet Alert
05/05/2023Buy Now332.1%Morgan Stanley
Tejas Savant
$15 → $14MaintainsEqual-WeightGet Alert
02/16/2023Buy Now362.96%Morgan Stanley
Tejas Savant
$16 → $15MaintainsEqual-WeightGet Alert
02/15/2023Buy Now116.05%Credit Suisse
Dan Leonard
→ $7Reiterates → UnderperformGet Alert
01/05/2023Buy Now362.96%Scotiabank
Sung Ji Nam
→ $15Initiates → Sector OutperformGet Alert
12/21/2022Buy Now332.1%Piper Sandler
David Westenberg
$7.5 → $14UpgradeNeutral → OverweightGet Alert
11/07/2022Buy Now393.83%Morgan Stanley
Tejas Savant
$17 → $16MaintainsEqual-WeightGet Alert
10/26/2022Buy Now131.48%Piper Sandler
David Westenberg
$12 → $7.5MaintainsNeutralGet Alert
08/25/2022Buy Now146.91%Credit Suisse
Dan Leonard
→ $8Initiates → UnderperformGet Alert
08/17/2022Buy Now270.37%Piper Sandler
David Westenberg
$7.5 → $12MaintainsNeutralGet Alert
06/03/2022Buy Now131.48%Piper Sandler
David Westenberg
→ $7.5Initiates → NeutralGet Alert
05/24/2022Buy Now208.64%Goldman Sachs
Salveen Richter
$14 → $10MaintainsNeutralGet Alert
05/06/2022Buy Now455.56%Morgan Stanley
Tejas Savant
$27 → $18MaintainsEqual-WeightGet Alert
02/16/2022Buy Now825.93%BTIG
Mark Massaro
$35 → $30MaintainsBuyGet Alert
02/15/2022Buy Now733.33%Morgan Stanley
Tejas Savant
$46 → $27MaintainsEqual-WeightGet Alert
08/06/2021Buy Now1504.94%Goldman SachsMaintainsNeutralGet Alert

FAQ

Q

What is the target price for Adaptive Biotechnologies (ADPT) stock?

A

The latest price target for Adaptive Biotechnologies (NASDAQ:ADPT) was reported by BTIG on April 4, 2024. The analyst firm set a price target for $5.00 expecting ADPT to rise to within 12 months (a possible 54.32% upside). 8 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Adaptive Biotechnologies (ADPT)?

A

The latest analyst rating for Adaptive Biotechnologies (NASDAQ:ADPT) was provided by BTIG, and Adaptive Biotechnologies maintained their buy rating.

Q

When was the last upgrade for Adaptive Biotechnologies (ADPT)?

A

The last upgrade for Adaptive Biotechnologies Corp happened on December 21, 2022 when Piper Sandler raised their price target to $14. Piper Sandler previously had a neutral for Adaptive Biotechnologies Corp.

Q

When was the last downgrade for Adaptive Biotechnologies (ADPT)?

A

There is no last downgrade for Adaptive Biotechnologies.

Q

When is the next analyst rating going to be posted or updated for Adaptive Biotechnologies (ADPT)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Adaptive Biotechnologies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Adaptive Biotechnologies was filed on April 4, 2024 so you should expect the next rating to be made available sometime around April 4, 2025.

Q

Is the Analyst Rating Adaptive Biotechnologies (ADPT) correct?

A

While ratings are subjective and will change, the latest Adaptive Biotechnologies (ADPT) rating was a maintained with a price target of $6.00 to $5.00. The current price Adaptive Biotechnologies (ADPT) is trading at is $3.24, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch